ArticleDiabetes therapy : research, treatment and education of diabetes and related disorders2017

Evaluating the Long-Term Cost-Effectiveness of Daily Administered GLP-1 Receptor Agonists for the Treatment of Type 2 Diabetes in the United Kingdom.

Barnaby Hunt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.